U.S. Markets closed

Pfizer Is Buying Array BioPharma, Seeking to Broaden Lineup of Cancer Drugs

Josh Nathan-Kazis

The pharmaceutical company Pfizer said it would buy Array BioPharma, a maker of cancer drugs, for $48 a share in cash.